Mutation of Von Hippel-Lindau Tumor Suppressor Gene in Sporadic Clear Renal Cell Carcinoma and Its Significance

Qi Chen
2007-01-01
Abstract:Background and purpose:von Hippel-Lindau (VHL) gene is one of the tumor suppressor genes and plays an important role in the carcinogenesis of clear cell renal cell carcinoma. The aim of this study was to determine the characteristics of VHL gene mutations in the sporadic clear cell renal cell carcinoma in the Chinese populations and further analyze the correlations between VHL gene mutations and clinicopathological parameters. Methods:72 patients were enrolled in this study. The specimens of tumor and normal tissue were collected at 1 hour post-operation, then immediately stored in the liquid nitrogen. The tissues were unfrozen and total genomic DNA was extracted from the samples. Different primers were designed to amplify variant exons and mutations were analyzed using double strand sequencing of VHL DNA by PCR method.Results:Mutations were detected in 25 of 72 sporadic clear cell renal cell carcinomas (35%), including 13 frame shift mutations, 8 missense mutations, 3 nonsense mutations and 1 silent mutation. The affected sites were exon 1 in six mutations, exon 2 in five, exon 3 in twelve and intron in two. Six out of 25 mutations were in the region of codon 157-166, where the VHL protein bound to Elongin C and Elongin B. No significant differences were observed between various pathological stages and grades.Conclusions:The percentage of VHL gene mutations was unexpectedly low in sporadic clear cell renal cell carcinoma. Mutations were mainly located in exon 3, where there might be a hot-spot mutational region. No correlations between VHL gene mutation and clinicopathological parameters were found. VHL gene mutation might be an early event in the carcinogenesis of clear cell renal cell carcinoma.
What problem does this paper attempt to address?